1ARG.L
Get informed when a big investor buys or sells
+ Follow| Market cap | $1.71 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | 1.33 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
The Leverage Shares - 1x ARK Genomic ETP is designed to precisely mirror the financial performance of the ARK Genomic Revolution ETF. Its core purpose is to provide investors with a direct, one-to-one exposure to the returns generated by this particular underlying asset.